中国医院药学杂志2024,Vol.44Issue(5) :506-512.DOI:10.13286/j.1001-5213.2024.05.04

液相色谱串联质谱法测定人血浆中英夫利昔单抗浓度

Determination of infliximab in human plasma by liquid chromatography tandem-mass spectrometry

李宁红 向东 刘璐 余恒毅 李喜平 邱丽慧 赵婷慧 贡雪芃
中国医院药学杂志2024,Vol.44Issue(5) :506-512.DOI:10.13286/j.1001-5213.2024.05.04

液相色谱串联质谱法测定人血浆中英夫利昔单抗浓度

Determination of infliximab in human plasma by liquid chromatography tandem-mass spectrometry

李宁红 1向东 1刘璐 1余恒毅 1李喜平 1邱丽慧 1赵婷慧 1贡雪芃1
扫码查看

作者信息

  • 1. 华中科技大学同济医学院附属同济医院药学部,湖北武汉 430030
  • 折叠

摘要

目的:建立液相色谱串联质谱法(liquid chromatography tandem-mass spectrometry,LC-MS/MS)测定人血浆中英夫利昔单抗血药浓度的方法.方法:采用甲醇沉淀提取血浆中的英夫利昔单抗,经变性、还原、烷基化后,加入胰酶裂解成大量肽段,通过分析特征性肽段并进行测定,选用贝伐珠单抗特征肽段作为内标.色谱柱为Ultimate LP C18(5 μm,21 mm× 100 mm),以含0.1%甲酸的水和含0.1%甲酸的乙腈为流动相进行梯度洗脱.采用电喷雾离子源,以多反应监测模式进行正离子扫描.对所建立的LC-MS/MS方法进行方法学验证并利用该方法测定患者的血浆药物浓度.结果:英夫利昔单抗在1~100 μg·mL-1范围内线性关系良好,批内和批间准确度在85.0%~115.0%,批内和批间精密度均小于15%,特异性、基质效应、稳定性、选择性、残留均符合指导原则要求.10例炎症性肠病患者体内英夫利昔单抗血药浓度在3.61~19.60 μg·mL-1范围内.结论:该研究建立的LC-MS/MS方法可以准确、精密测定英夫利昔单抗血药浓度,为临床监测英夫利昔单抗提供了有效的检测手段.

Abstract

OBJECTIVE To establish a liquid chromatography tandem mass spectrometry(LC-MS/MS)method for the quantification of infliximab in human plasma.METHODS Infliximab was extracted from plasma by methanol.After denatur-ation,reduction and alkylation,trypsin was added to digest infliximab into a large number of peptides.Quantification was per-formed by analyzing signature peptide,and peptide of bevacizumab was used as the internal standard.The chromatographic col-umn was Ultimate LP C18(5 μm,21 mm×100 mm),and the mobile phases were water containing 0.1% formic acid and acetoni-trile containing 0.1%formic acid.The multiple reaction monitoring was performed in the positive electrospray ionization mode.The established LC-MS/MS method was validated and used to determine plasma drug concentrations of infliximab-treated patients.RESULTS Infliximab showed good correlation within the range of 1-100 μg·mL-1.The intra-and inter-batch accu-racy ranged from 85.0%-115.0%,and the intra-and inter-batch precision was within 15.0%.Specificity,matrix effect,stabil-ity,selectivity and carryover all met the requirements.The plasma concentrations of infliximab in 10 patients with inflammatory bowel disease ranged from 3.61 to 19.60 μg·mL-1.CONCLUSION The LC-MS/MS method established in our study can accu-rately and precisely determine the plasma concentration of infliximab,which provides an effective means for the clinical monitoring of infliximab.

关键词

英夫利昔单抗/治疗药物监测/液相色谱串联质谱/血药浓度检测

Key words

infliximab/therapeutic drug monitoring/liquid chromatography tandem-mass spectrometry/blood drug concen-tration detection

引用本文复制引用

基金项目

湖北省自然科学基金项目(2022CFB142)

出版年

2024
中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
参考文献量31
段落导航相关论文